Christophe Dubois

Letter: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?

March 20, 2023 | 10.4244/EIJ-D-22-00998

Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system

Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa R, Chamié D, de Ribamar Costa J, Kereiakes D, Abizaid A, Colombo A

December 18, 2020 | 10.4244/EIJ-D-20-00763

The drug-eluting resorbable magnesium vascular scaffold in complex coronary bifurcations: insights from an in vivo multimodality imaging study

Bennett J, Vanhaverbeke M, Vanden Driessche N, Hiltrop N, Adriaenssens T, Desmet W, Sinnaeve P, Dubois C

April 20, 2018 | 10.4244/EIJ-D-17-00248

Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Dubois C, Dens J, Farah B, Carrié D, Walsh S, Oldroyd K, Varenne O, El-Jack S, Moreno R, Christen T, Allocco D

April 20, 2018 | 10.4244/EIJ-D-17-00529

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

Jensen C, Naber C, Urban P, Ong P, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H, Morice M

March 20, 2018 | 10.4244/EIJ-D-17-00720

Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial

Teeuwen K, Spoormans E, Bennett J, Dubois C, Desmet W, Ughi G, Belmans A, Kelder J, Tijssen J, Agostoni P, Suttorp MJ, Adriaenssens T

August 4, 2017 | 10.4244/EIJ-D-17-00261

Belgium: coronary and structural heart interventions from 2010 to 2015

Desmet W, Aminian A, Kefer J, Dens J, Bosmans J, Claeys M, Dubois C, Gach O, Janssens L, Schröder E, Vermeersch P, Carlier M, Benit E, Hanet C

May 15, 2017 | 10.4244/EIJ-D-16-00825

COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial

Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi G, Sinnaeve P, Vrolix M, D’hooge J, Adriaenssens T

April 20, 2016 | 10.4244/EIJY15M05_02

STACCATO (Assessment of Stent sTrut Apposition and Coverage in Coronary ArTeries with Optical coherence tomography in patients with STEMI, NSTEMI and stable/unstable angina undergoing everolimus vs. biolimus A9-eluting stent implantation): a randomised controlled trial

Adriaenssens T, Ughi G, Dubois C, De Cock D, Onsea K, Bennett J, Wiyono S, Sinnaeve P, Coosemans M, Ferdinande B, Belmans A, D’hooge J, Desmet W

April 8, 2016 | 10.4244/EIJV11I14A313

Optical coherence tomography-based assessment of bifurcation stenting using the Axxess™ Biolimus A9™-eluting stent system

Hiltrop N, Ughi G, Dubois C, Adriaenssens T

January 20, 2016 | 10.4244/EIJV11I9A208

Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial

Adriaenssens T, Dens J, Ughi G, Bennett J, Dubois C, Sinnaeve P, Wiyono S, Coosemans M, Belmans A, D’hooge J, Vrolix M, Desmet W

August 19, 2014 | 10.4244/EIJV10I4A77

Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study

Buysschaert I, Dubois C, Dens J, Ormiston J, Worthley SG, McClean D, Ottervanger J, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky A, Bichalska M, Meis S, Verheye S

September 27, 2013 | 10.4244/EIJV9I5A93

A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry

Agostoni P, Foley DP, Lesiak M, Belkacemi A, Dens J, Kumsars I, Scott B, Oemrawsingh P, Dubois C, Garcia E, Lefèvre T, Stella P

March 21, 2012 | 10.4244/EIJV7I11A204

Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study

Adriaenssens T, Dens J, Ughi G, Coosemans M, Onsea K, Dubois C, Sinnaeve P, Vrolix M, Desmet W

May 17, 2011

The AXXESS™ Self-Expanding Biolimus A9™ Eluting Stent System for coronary bifurcation lesions

Dubois C, Wijns W

January 11, 2011

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

Serruys P, Garg S, Abizaid A, Ormiston J, Windecker S, Verheye S, Dubois C, Stewart J, Hauptmann K, Schofer J, Stangl K, Witzenbichler B, Wiemer M, Barbato E, de Vries T, Drijver A-M, Otake H, Meredith L, Toyloy S, Fitzgerald P

June 30, 2010

Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial

Morice M, Bestehorn H-P, Carrié D, Macaya C, Aengevaeren W, Wijns W, Dubois C, de Winter R, Verheye S, Hoffmann S, Pachinger O, Di Mario C

May 20, 2006

Christophe Dubois

Latest news